Phase I trial combining motexafin gadolinium with docetaxel in the treatment of advanced solid tumors.

被引：0

作者：

Phan, S

Messina, P

Buffan, M

Salemi, ML

Pandya, K

Wilmot, JP

机构：

[1] Pharmacycl Inc, Sunnyvale, CA USA

[2] Univ Rochester, James P Wilmot Canc Ctr, Rochester, NY USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

3203

引用

页码：244S / 244S

页数：1

共 50 条

[41] A phase I study of carboxyamidotriazole orotate (CTO) in of advanced solid tumors.
Sandler, Alan
Taylor, Matthew Hiram
Urba, Walter John
Omuro, Antonio Marcilio Padula
Anderson, Barry Douglas
Hansen, Daniel
Fisher, Brenda
Claeys, Alisa J.
Greathouse, Amy
McLean, Sean
Karmali, Rashida A.
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
[42] A phase I study of PT-112 in advanced solid tumors.
Karp, Daniel D.
Camidge, D. Ross
Bryce, Alan Haruo
Jimeno, Jose
Infante, Jeffrey R.
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[43] Phase I study of sapacitabine and seliciclib in patients with advanced solid tumors.
Tolaney, Sara M.
Hilton, John Frederick
Cleary, James M.
Gandhi, Leena
Kwak, Eunice Lee
Clark, Jeffrey W.
Wolanski, Andrew
Bell, Tracy Demeo
Rodig, Scott J.
Chiao, Judy H.
Blake, David
Shapiro, Geoffrey
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[44] A phase I QTc study of tivozanib in patients with advanced solid tumors.
Chadha, Manpreet Kaur
Infante, Jeffrey R.
Cotreau, Monette M.
Jacobson, Lindsey
Strahs, Andrew Louis
Slichenmyer, William
Vargo, Dennis
Moore, Kathleen N.
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
[45] Phase I study of weekly oral docetaxel (ModraDoc001) plus ritonavir in patients with advanced solid tumors.
Marchetti, Serena
Stuurman, Frederik
Koolen, Stijn
Moes, Johannes
Hendrikx, Jeroen
Thijssen, Bas
Huitema, Alwin D. R.
Nuijen, Bastiaan
Rosing, Hilde
Keessen, Marianne
Voest, Emile E.
Mergui-Roelvink, M.
Beijnen, Jos H.
Schellens, Jan H. M.
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[46] Phase I trial of bortezomib (PS-341) in combination with docetaxel in patients with advanced solid tumors
Messersmith, WA
Baker, SD
Dinh, K
Lassiter, LK
Akdamar, RA
Wright, JJ
Donehower, RC
Carducci, MA
Armstrong, DK
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 208S - 208S
[47] Phase I clinical trial of temozolomide and methoxyamine (TRC-102) in patients with advanced solid tumors.
Eads, Jennifer Rachel
Krishnamurthi, Smitha S.
Saltzman, Joel N.
Meropol, Neal J.
Bokar, Joseph A.
Gibbons, Joseph
Koon, Henry B.
Sharma, Neelesh
Savvides, Panayiotis
Pink, John
Xu, Yan
Beumer, Jan Hendrik
Fu, Pingfu
Beatty, Kristi
Kane, Donna
Rodal, Mary Beth
Czalkiewicz, Julianne
Riendeau, John
Gerson, Stanton L.
Dowlati, Afshin
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[48] Phase I trial of SU011248, a novel tyrosine kinase inhibitor in advanced solid tumors.
Rosen, L
Mulay, M
Long, J
Wittner, J
Brown, J
Martino, AM
Bello, CL
Walter, S
Scigalla, P
Zhu, J
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (23) : 284S - 284S
[49] Safety and pharmacokinetics of intravenous VEGF Trap in a phase I clinical trial of patients with advanced solid tumors.
Dupont, J
Rothenberg, ML
Spriggs, DR
Cedarbaum, JM
Furfine, ES
Cohen, DP
Dancy, I
Lee, HS
Cooper, W
Lockhart, AC
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 199S - 199S
[50] Phase I trial of the triplet veliparib + VX-970+cisplatin in patients with advanced solid tumors.
Coyne, Geraldine Helen O'Sullivan
Kummar, Shivaani
Meehan, Robert S.
Juwara, Lamin
Piekarz, Richard
Sharon, Elad
Streicher, Howard
Conley, Barbara A.
Takebe, Naoko
Harris, Lyndsay
Doyle, Austin
Quinn, Mary Flanagan
Rubinstein, Larry
Wilsker, Deborah
Kinders, Robert J.
Parchment, Ralph E.
Levy, Elliot B.
Doroshow, James H.
Chen, Alice P.
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35

← 1 2 3 4 5 →